90-325.3. No liability to heirs for outstanding debt related to use of investigational drugs, biological products, or devices.
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment. (2015-137, s. 1.)
Structure North Carolina General Statutes
North Carolina General Statutes
Chapter 90 - Medicine and Allied Occupations
Article 23A - Right to Try Act.
§ 90-325 - Short title; purpose.
§ 90-325.4 - Sanctions against health care providers prohibited.
§ 90-325.5 - Prohibited conduct by State officials.
§ 90-325.7 - Insurance coverage of clinical trials.
§ 90-325.17 - Authorized treatments.
§ 90-325.18 - Institutional review boards; annual report; rules.
§ 90-325.20 - Sanctions against physicians prohibited.